Grifols, S.A.
OTC: GIFLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Jose Ignacio Abia Buenache
- Employees
- 23,833
- Headquarters
- Barcelona, Spain
- IPO year
- 2008
- Market cap
- $7.1B
- Website
- https://www.grifols.com
Loading GIFLF…
Loading profile data…Frequently asked questions about GIFLF
What does Grifols, S.A. (GIFLF) do?
Grifols, S.A., a company established in Barcelona, Spain, in 1940, specializes in the sourcing, production, and sale of therapeutic products, principally derived from blood plasma. Its diverse activities are structured across five main divisions. The Bioscience division spearheads the research, development, manufacturing, and commercialization o...
Where does GIFLF trade?
Grifols, S.A. (GIFLF) trades on the Other OTC.
What sector is GIFLF in?
Grifols, S.A. (GIFLF) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Grifols, S.A.?
Jose Ignacio Abia Buenache is the chief executive officer of Grifols, S.A. (GIFLF).
Where is Grifols, S.A. headquartered?
Grifols, S.A. is headquartered in Spain.
Does GIFLF pay a dividend?
Yes — Grifols, S.A. (GIFLF) paid a trailing twelve-month dividend of USD 0.18 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did GIFLF go public?
Grifols, S.A. (GIFLF) completed its initial public offering in 2008.